Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ARQT
TMDX
Add up to 3 more stocks
ARQT
Arcutis Biotherapeutics, Inc.
-4.43%
$24.04-1.11Delayed quote: Oct 6, 2026, 3:05 PM EDT
Market Cap
$3.01B
52W Range
$19.30 - $31.77
TMDX
TransMedics Group, Inc.
-2.52%
$80.90-2.09Delayed quote: Oct 6, 2026, 3:05 PM EDT
Market Cap
$2.80B
52W Range
$60.10 - $156.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 115.28 | 20.96 |
| Forward P/E | 48.35 | 55.15 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 13.63 | 5.40 |
| P/S Ratio | 6.48 | 4.18 |
| P/FCF Ratio | 76.79 | 35.37 |
| EV/EBITDA | 82.97 | 27.04 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 91.1% | 58.7% |
| Operating Margin | -3.3% | 12.2% |
| Net Margin | 6.2% | 22.7% |
| ROE | 12.9% | 29.3% |
| ROA | 5.8% | 10.4% |
| ROIC | 9.9% | 5.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.92 | 6.62 |
| Quick Ratio | 2.67 | 6.07 |
| Debt/Equity | 0.52 | 1.67 |
| Interest Coverage | -1.01 | 7.88 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.